Shares of Aterian (NASDAQ: ATER) tanked 23.6% in November, according to data from S&P Global Market Intelligence. The consumer products roll-up reported another disappointing earnings result, and its founder and chief executive officer, Yaniv Sarig, continues to post strange messages on Twitter. Aterian is a technology-focused consumer products company that buys brands that sell products on Amazon and other e-commerce marketplaces. Read More...
Motley Fool
Why Shares of Pfizer, Ocugen, and Vaxart Are Losing Ground Today
Shares of the COVID-19 vaccine makers Pfizer (NYSE: PFE), Ocugen (NASDAQ: OCGN), and Vaxart (NASDAQ: VXRT) are all moving in the wrong direction today. Specifically, Pfizer’s stock is down by approximately 4%, Ocugen’s equity is in the red by 5.64%, and Vaxart’s shares are underwater by a hefty 8.7%, as of 12:23 p.m. ET Monday afternoon. On Sunday, the White House’s chief medical advisor, Dr. Anthony Fauci, said that the preliminary data regarding the severity of the omicron variant was “encouraging.”
Add Comment